ChrysCapital acquires controlling 70.68% stake in Novartis India in first majority pharma investment
India’s private equity firm ChrysCapital has completed the acquisition of a controlling 70.68% stake in Novartis India Ltd…
ChrysCapital Acquires 70.68% Controlling Stake in Novartis India, Appoints Vikas Gupta as MD & CEO
Private equity firm ChrysCapital has completed the acquisition of a controlling 70.68% stake in Novartis India Ltd (NIL),…
PE firm ChrysCapital acquires Swiss parent’s stake in Novartis India
Private equity firm ChrysCapital has completed the acquisition of a controlling 70.68 per cent stake in Novartis India…